1H-NMR-Based Metabolomic Profiling and Phylogenetic Analysis of Dendrobium Species Identify Lineage-Correlated Metabolites in the Main Clades
Chemical and Pharmaceutical Bulletin · 20.01.2026 · 74 (1) · 90-97
DOI: 10.1248/cpb.c25-00555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 20.01.2026. Verfasst von Tomoko Takamiya und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan. Hauptthemen laut MEDLINE: Dendrobium, Phylogeny, Metabolomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Dendrobium Sw. is one of the largest genera in the Orchidaceae. Most species belong to one of two major clades (the Asian and the Australasian clades) based on morphology and phylogenetic analyses using DNA sequences. Several Dendrobium species in the Asian clade are used in traditional herbal medicine, and many compounds have been isolated from them (e.g., phenanthrene derivatives, bibenzyl derivatives, and polysaccharides). Conversely, there are only a few reports on the compounds contained in the Australasian clade species. Due to its size and diversity, the Australasian clade could be expected to contain compounds of potential medicinal value as well. Previously, we constructed the HPLC profile of 18 Dendrobium species and identified the phenanthrene derivative 1,5-dimethoxyphenanthrene-2,7-diol (1) as a characteristic compound in certain species of the Australasian clade. In this study, we performed metabolic analyses based on 1H-NMR to identify lineage-correlated metabolites for the Australasian clade. NMR profiling analysis also showed that 1 is a characteristic compound of the Australasian clade species. Additionally, pinoresinol (2) was predominantly detected in the Australasian clade. While syringaresinol (3) was widely detected in species from both clades, specimens from the Australasian clade tended to have higher concentrations. The simple 1H-NMR profiling method enables rapid comparison of metabolites across multiple species, providing new insights into metabolic differences associated with evolutionary lineages that were not detectable by the previous HPLC profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.
- Herbarium, Royal Botanic Gardens, Kew, London, TW9 3AE, U.K.
- Tsukuba Botanical Garden, National Museum of Nature and Science, 4-1-1 Amakubo, Tsukuba, Ibaraki 305-0005, Japan.
- CBI Research Institute, 3-11-1 Shibaura, Minato-ku, Tokyo 108-0023, Japan.
Zitieren
APA
Takamiya, T., Yahagi, T., Miyamoto, A., Shibazaki, S., Won, J., Miwa, Y., Metori, K., Saito, H., Uchiyama, T., Schuiteman, A., Kitanaka, S., Yukawa, T., Iijima, H., & Matsuzaki, K. (2026). 1H-NMR-Based Metabolomic Profiling and Phylogenetic Analysis of Dendrobium Species Identify Lineage-Correlated Metabolites in the Main Clades. Chemical and Pharmaceutical Bulletin, 74(1), 90-97. https://doi.org/10.1248/cpb.c25-00555
Vancouver
Takamiya T, Yahagi T, Miyamoto A, Shibazaki S, Won J, Miwa Y, et al. 1H-NMR-Based Metabolomic Profiling and Phylogenetic Analysis of Dendrobium Species Identify Lineage-Correlated Metabolites in the Main Clades. Chemical and Pharmaceutical Bulletin. 2026;74(1):90-97. doi:10.1248/cpb.c25-00555
BibTeX
@article{Takamiya2026,
author = {Takamiya, Tomoko and Yahagi, Tadahiro and Miyamoto, Aoi and Shibazaki, Shohei and Won, Jihee and Miwa, Yudai and Metori, Koichi and Saito, Hiroaki and Uchiyama, Taketo and Schuiteman, André and Kitanaka, Susumu and Yukawa, Tomohisa and Iijima, Hiroshi and Matsuzaki, Keiichi},
title = {1H-NMR-Based Metabolomic Profiling and Phylogenetic Analysis of Dendrobium Species Identify Lineage-Correlated Metabolites in the Main Clades},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2026},
volume = {74},
number = {1},
pages = {90--97},
doi = {10.1248/cpb.c25-00555}
}
EUVIMED